Recurrent Dupuytren’s contracture is common regardless of the initial intervention. Collagenase clostridium histolyticum (CCH) is approved for treatment of adult patients with Dupuytren’s contracture with a palpable cord. This study assessed safety and efficacy of CCH for the retreatment of recurrent contractures in joints that were previously effectively treated with CCH.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Hand Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Clinical Paper Session 08: Dupuytren
Friday, September 19, 2014 • 2:13–2:20 PM
Keyword: Hand and Wrist, Diseases and Disorders
© 2014 Published by Elsevier Inc.